Skip to article
Astra

Hepatology

Ascites

New or worsening ascites requires prompt paracentesis, fluid-pattern interpretation, and early detection of spontaneous bacterial peritonitis, renal dysfunction, and portal-hypertensive decompensation. Management is driven by etiology, ascites severity, response to fluid removal, and candidacy for TIPS or liver transplantation.

Clinical question: How should physicians rapidly classify, investigate, and manage new or worsening ascites while identifying infection and refractory portal-hypertensive disease?

Initial action

When ascites requires immediate diagnostic paracentesis

Do not attribute fluid accumulation to cirrhosis without fluid analysis.

Perform diagnostic paracentesis for all new-onset ascites. Obtain abdominal ultrasound before the procedure for fluid confirmation and site selection. In cirrhosis, perform the tap without delay at hospital admission and repeat diagnostic evaluation when ascites worsens or when gastrointestinal bleeding, shock, fever, systemic inflammation, gastrointestinal symptoms, worsening kidney or liver function, or hepatic encephalopathy occurs. WileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online Libraryeasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...

Send ascitic fluid for cell count with differential, albumin, and total protein; obtain serum albumin on the same day for SAAG calculation. Send culture when infection is suspected, ideally by bedside inoculation into aerobic and anaerobic blood-culture bottles before antimicrobials. Cytology requires a larger sample than the approximately 50 mL generally sufficient for routine diagnostic studies. ScienceDirectSerum-Ascites Albumin Gradient - an overviewScienceDirectPerforming Abdominal Paracentesis - ScienceDirectPubMedEvidence-based clinical practice guidelines for Liver Cirrhosis 2020

Ascites in cirrhosis is a decompensating event rather than an isolated symptom: five-year survival declines from approximately 80% in compensated cirrhosis to approximately 30% after ascites develops. Clinically significant ascites and associated complications should prompt consideration of liver-transplant evaluation. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...aasldDiagnosis, Evaluation and Management of Ascites, Spontaneous ...

Initial ascitic-fluid studies and the decision each result changes. WileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online LibraryScienceDirectSerum-Ascites Albumin Gradient - an overviewScienceDirectPerforming Abdominal Paracentesis - ScienceDirecteasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...PubMedEvidence-based clinical practice guidelines for Liver Cirrhosis 2020
TestActionable resultInterpretation and next action
Cell count and differentialNeutrophils >250/mm3Diagnose SBP and initiate treatment; do not await culture confirmation. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...
Ascitic albumin plus same-day serum albuminSAAG ≥1.1 g/dLSupports portal-hypertensive ascites; integrate total protein and clinical context. WileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online LibraryPubMedEvidence-based clinical practice guidelines for Liver Cirrhosis 2020
Ascitic total protein<2.5 g/dL with SAAG ≥1.1 g/dLPattern strongly supports cirrhosis with portal hypertension. WileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online Library
Ascitic total protein≥2.5 g/dL with SAAG ≥1.1 g/dLPattern usually indicates right-heart failure; direct cardiac evaluation accordingly. WileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online Library
CulturePositive culture with PMN <250/mm3Bacterascites; treat if symptomatic, while asymptomatic patients should undergo repeat paracentesis. ScienceDirectAscites - an overview | ScienceDirect Topics

Fluid pattern

Use SAAG and ascitic protein to direct the etiologic workup

Classify portal-hypertensive versus nonportal ascites before committing to cirrhosis-directed therapy.

Calculate SAAG as serum albumin minus ascitic albumin. A SAAG ≥1.1 g/dL indicates portal hypertension and correlates with a hepatic vein–portal vein pressure gradient greater than 11 mm Hg; a SAAG <1.1 g/dL redirects the evaluation toward nonportal mechanisms. Although SAAG is highly useful, interpret it with the total clinical picture because exceptions occur. WileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online LibraryPubMedEvidence-based clinical practice guidelines for Liver Cirrhosis 2020

For high-SAAG ascites, ascitic total protein is the key discriminator. A protein concentration <2.5 g/dL supports cirrhosis and portal hypertension, whereas protein ≥2.5 g/dL usually indicates right-heart failure. A high-SAAG result therefore should not automatically be labeled cirrhotic ascites when cardiac congestion is plausible. WileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online Library

For low-SAAG ascites, prioritize peritoneal malignancy, chronic peritoneal infection including tuberculosis, and nephrotic syndrome. Evaluate for nephrotic syndrome or protein-losing enteropathy when the clinical setting supports either diagnosis. Pancreatic ascites may produce an elevated PMN count but generally remains low-SAAG, so neutrophilia alone does not establish SBP in a nonportal fluid pattern. WileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online Library

Etiologic branching by SAAG and ascitic total protein. WileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online LibraryScienceDirectIntranodal lymphangiography in the treatment of chylous ascites - ScienceDirectWolters KluwerChylous Ascites From Cirrhosis-Related Portal... : ACG Case Reports JournalPubMedEvidence-based clinical practice guidelines for Liver Cirrhosis 2020
Fluid patternMost likely mechanism or causeNext diagnostic direction
SAAG ≥1.1 g/dL; protein <2.5 g/dLCirrhosis with portal hypertensionAssess decompensation, infection, kidney function, and response to ascites treatment. WileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online Library
SAAG ≥1.1 g/dL; protein ≥2.5 g/dLUsually right-heart failureEvaluate for cardiac congestion rather than assuming cirrhosis. WileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online Library
SAAG <1.1 g/dLPeritoneal malignancy, tuberculosis, nephrotic syndrome, or pancreatic ascitesUse clinical context to pursue cytology, chronic infection evaluation, renal protein-loss assessment, or pancreatic evaluation. WileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online Library
Milky fluid; triglycerides >200 mg/dLChylous ascitesEvaluate for malignancy, cirrhosis-related portal hypertension, postoperative or traumatic lymphatic leak, and infection. ScienceDirectIntranodal lymphangiography in the treatment of chylous ascites - ScienceDirectWolters KluwerChylous Ascites From Cirrhosis-Related Portal... : ACG Case Reports Journal

Infection

Recognize and act on spontaneous bacterial peritonitis

The ascitic neutrophil count determines immediate management.

Diagnose SBP when ascitic fluid neutrophils exceed 250/mm3. This threshold applies whether neutrophils are measured microscopically or by flow cytometry-based automated counting; reagent strips do not have clear evidence for routine diagnosis. In a traumatic paracentesis with ascitic red cells >10,000/mm3, correct the PMN count by subtracting 1 PMN for every 250 red cells/mm3. ScienceDirectSerum-Ascites Albumin Gradient - an overvieweasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...

Culture-negative neutrocytic ascites has PMN ≥250/mm3 with a negative culture and remains an infected-ascites phenotype requiring treatment. In contrast, monomicrobial nonneutrocytic bacterascites has a positive culture with PMN <250/mm3: treat symptomatic patients, but in asymptomatic patients repeat paracentesis and start antibiotics if the repeat PMN count reaches ≥250/mm3. ScienceDirectAscites - an overview | ScienceDirect Topics

In SBP with increased or rising serum creatinine, administer albumin 1.5 g/kg within 6 hours of diagnosis followed by 1 g/kg on day 3. This regimen targets the high-risk renal phenotype rather than routine albumin use for every infected ascites presentation. BMJGuidelines on the management of ascites in cirrhosis - GutBMJGuidelines on the management of ascites in cirrhosis - Gut - The BMJPubMedOptimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMC

Ascitic-fluid infection phenotypes and immediate action. ScienceDirectSerum-Ascites Albumin Gradient - an overviewScienceDirectAscites - an overview | ScienceDirect Topicseasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...
PhenotypeFluid findingsManagement decision
SBPPMN >250/mm3Treat as SBP; culture result does not delay treatment. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...
Culture-negative neutrocytic ascitesPMN ≥250/mm3 with negative cultureManage as infected ascites requiring treatment. ScienceDirectAscites - an overview | ScienceDirect Topics
Monomicrobial nonneutrocytic bacterascitesSingle-organism culture positive; PMN <250/mm3Treat if symptomatic; if asymptomatic, repeat paracentesis and treat if PMN becomes ≥250/mm3. ScienceDirectAscites - an overview | ScienceDirect Topics
Polymicrobial bacterascitesMultiple organisms; PMN <250/mm3Assess for needle-related gut puncture or another secondary source. ScienceDirectAscites - an overview | ScienceDirect Topics

Volume management

Manage large-volume and refractory cirrhotic ascites

Paracentesis and albumin replacement are central when ascites is tense, symptomatic, or diuretic-refractory.

Large-volume paracentesis is standard care for large-volume ascites and is used with diuretic therapy when applicable. In diuretic-refractory ascites, remove as much fluid as feasible for symptom control. Bedside paracentesis is generally safe, and repeated therapeutic paracentesis is commonly used when fluid is refractory to fluid restriction and diuretics. BMJGuidelines on the management of ascites in cirrhosis - GutNEJMTreatment of Patients with CirrhosisScienceDirectPerforming Abdominal Paracentesis - ScienceDirect

After paracentesis removing >5 L, infuse 20% or 25% albumin at 8 g per liter of ascites removed. For removal of <5 L, consider the same 8 g/L replacement in acute-on-chronic liver failure or when post-paracentesis acute kidney injury risk is high. Albumin remains the preferred plasma expander in this setting. BMJGuidelines on the management of ascites in cirrhosis - GutBMJGuidelines on the management of ascites in cirrhosis - Gut - The BMJ

Consider TIPS in selected patients with refractory or recurrent ascites, and assess transplant candidacy at the same decision point. TIPS may improve ascites control and, in more recent randomized studies using contemporary selection and stent approaches, improved survival compared with large-volume paracentesis; selection is crucial because the earlier trials commonly excluded more severe liver disease. BMJGuidelines on the management of ascites in cirrhosis - Gut - The BMJBMJTransjugular intrahepatic portosystemic stent-shunt in the ... - GutNatureLiver diseases: epidemiology, causes, trends and predictions - Nature

Procedure-centered escalation for cirrhotic ascites. BMJGuidelines on the management of ascites in cirrhosis - GutBMJGuidelines on the management of ascites in cirrhosis - Gut - The BMJBMJTransjugular intrahepatic portosystemic stent-shunt in the ... - GutNatureLiver diseases: epidemiology, causes, trends and predictions - NatureScienceDirectPerforming Abdominal Paracentesis - ScienceDirect
Clinical situationPrimary actionKey guardrail
Large, symptomatic ascitesTherapeutic large-volume paracentesis. BMJGuidelines on the management of ascites in cirrhosis - GutScienceDirectPerforming Abdominal Paracentesis - ScienceDirectGive 20% or 25% albumin 8 g/L removed when >5 L is removed. BMJGuidelines on the management of ascites in cirrhosis - GutBMJGuidelines on the management of ascites in cirrhosis - Gut - The BMJ
<5 L removed with ACLF or high post-paracentesis AKI riskConsider albumin 8 g/L removed. BMJGuidelines on the management of ascites in cirrhosis - GutBMJGuidelines on the management of ascites in cirrhosis - Gut - The BMJRecommendation is weaker than for >5 L removal. BMJGuidelines on the management of ascites in cirrhosis - GutBMJGuidelines on the management of ascites in cirrhosis - Gut - The BMJ
Refractory or recurrent ascitesConsider TIPS and liver-transplant evaluation. BMJGuidelines on the management of ascites in cirrhosis - Gut - The BMJBMJTransjugular intrahepatic portosystemic stent-shunt in the ... - GutNatureLiver diseases: epidemiology, causes, trends and predictions - NatureScreen for encephalopathy, infection, renal decline, cardiac dysfunction, pulmonary hypertension, bilirubin >50 micromol/L, and platelets <75 × 10^9/L. BMJTransjugular intrahepatic portosystemic stent-shunt in the ... - Gut
Transplant-eligible patient considered for TIPSDiscuss TIPS with the transplant center. BMJTransjugular intrahepatic portosystemic stent-shunt in the ... - GutDo not treat TIPS as a substitute for transplant planning. BMJTransjugular intrahepatic portosystemic stent-shunt in the ... - GutNatureLiver diseases: epidemiology, causes, trends and predictions - Nature

Long-term albumin: selective and unsettled

Long-term albumin is not equivalent to post-paracentesis replacement. In the ANSWER trial of 442 patients with persistent ascites, 40 g human albumin weekly for up to 18 months was associated with a 38% lower mortality hazard and fewer refractory-ascites, renal, encephalopathy, and infection events. Its role across decompensated cirrhosis remains debated, so use should be individualized rather than substituted for evaluation of refractory ascites, TIPS suitability, or transplantation. BMJchronic liver failure (ACLF) and the role of biomarkers - Gut

Beyond cirrhosis

Redirect management when ascites is nonportal or atypical

Fluid removal may relieve symptoms, but definitive control requires treating the driver.

A low-SAAG profile should prevent reflex escalation of portal-hypertension therapy. Peritoneal malignancy, chronic peritoneal infection, nephrotic syndrome, and pancreatic ascites each require a cause-specific diagnostic pathway; obtain cytology when malignancy is suspected, evaluate protein-loss disorders when indicated, and interpret pancreatic inflammation or leak in the setting of low-SAAG fluid. WileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online Library

Malignant ascites is associated with advanced cancer and significant morbidity. Use paracentesis for symptom relief and coordinate disease-directed oncologic assessment rather than treating the fluid pattern as cirrhotic ascites. Diuretics are described as a treatment mainstay, but the expected response depends on the underlying physiology and should not delay diagnostic clarification. JAMAMalignant Ascites: New Concepts in Pathophysiology, Diagnosis ...ScienceDirectPerforming Abdominal Paracentesis - ScienceDirect

For chylous ascites, distinguish lymphatic obstruction or leak from portal-hypertensive lymphatic overload. In adults in Western settings, tumors, cirrhosis, and postoperative leakage are common causes; lymphangiography may be a therapeutic option for refractory lymphatic leakage in selected cases. ScienceDirectIntranodal lymphangiography in the treatment of chylous ascites - ScienceDirectWolters KluwerChylous Ascites From Cirrhosis-Related Portal... : ACG Case Reports Journal

Escalation triggers that should redirect the working diagnosis. JAMAMalignant Ascites: New Concepts in Pathophysiology, Diagnosis ...WileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online LibraryScienceDirectIntranodal lymphangiography in the treatment of chylous ascites - ScienceDirectWolters KluwerChylous Ascites From Cirrhosis-Related Portal... : ACG Case Reports Journal
TriggerConcernNext action
SAAG <1.1 g/dLNonportal ascitesPrioritize malignancy, tuberculosis or other chronic peritoneal infection, nephrotic syndrome, and pancreatic causes. WileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online Library
Milky fluid with triglycerides >200 mg/dLChylous ascitesInvestigate malignancy, cirrhosis, postsurgical or traumatic lymphatic injury, and infection. ScienceDirectIntranodal lymphangiography in the treatment of chylous ascites - ScienceDirectWolters KluwerChylous Ascites From Cirrhosis-Related Portal... : ACG Case Reports Journal
High SAAG with protein ≥2.5 g/dLCardiac ascitesEvaluate for right-heart failure or congestive physiology. WileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online Library
Clinical concern for cancer or low-SAAG patternPeritoneal malignancyObtain cytology and pursue malignancy-directed assessment. JAMAMalignant Ascites: New Concepts in Pathophysiology, Diagnosis ...WileyUnexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online LibraryScienceDirectPerforming Abdominal Paracentesis - ScienceDirect

References

  1. Cirrhosis - Guidelines | BMJ Best Practicebestpractice.bmj.com · bestpractice.bmj.com
  2. Guidelines on the management of ascites in cirrhosis - Gutgut.bmj.com · gut.bmj.com
  3. Guidelines on the management of ascites in cirrhosis - Gut - The BMJgut.bmj.com · gut.bmj.com
  4. chronic liver failure (ACLF) and the role of biomarkers - Gutgut.bmj.com · gut.bmj.com
  5. Treatment of Patients with Cirrhosiswww.nejm.org · www.nejm.org
  6. Transjugular intrahepatic portosystemic stent-shunt in the ... - Gutgut.bmj.com · gut.bmj.com
  7. Does This Patient Have Ascites? How to Divine Fluid in the Abdomenjamanetwork.com · jamanetwork.com
  8. Malignant Ascites: New Concepts in Pathophysiology, Diagnosis ...jamanetwork.com · jamanetwork.com
  9. Liver diseases: epidemiology, causes, trends and predictions - Naturewww.nature.com · www.nature.com
  10. Unexplained ascites - Hernaez - 2016 - Clinical Liver Disease - Wiley Online Libraryonlinelibrary.wiley.com · onlinelibrary.wiley.com
  11. Serum-Ascites Albumin Gradient - an overviewwww.sciencedirect.com · www.sciencedirect.com
  12. Performing Abdominal Paracentesis - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  13. Ascites - an overview | ScienceDirect Topicswww.sciencedirect.com · www.sciencedirect.com
  14. The Epidemiology of Ascites in a Multi‐Ethnic Asian Population - Sinnanaidu - 2025 - JGH Open - Wiley Online Libraryonlinelibrary.wiley.com · onlinelibrary.wiley.com
  15. Intranodal lymphangiography in the treatment of chylous ascites - ScienceDirectwww.sciencedirect.com · www.sciencedirect.com
  16. Chylous Ascites From Cirrhosis-Related Portal... : ACG Case Reports Journaljournals.lww.com · journals.lww.com
  17. Optimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians - PMCpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  18. The AASLD Clinical Practice Guidelines: A Critical Review of Scientific Evidence and Evolving Recommendations - PMCpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  19. [PDF] EASL Clinical Practice Guidelines for the management of patients ...easl.eu · easl.eu
  20. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. - Abstractpubmed.ncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov
  21. [PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLeasl.eu · easl.eu
  22. Cirrhosis & Complications Archives - EASL-The Home of Hepatology.easl.eu · easl.eu
  23. Evidence-based clinical practice guidelines for Liver Cirrhosis 2020pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  24. Diagnosis, Evaluation and Management of Ascites, Spontaneous ...www.aasld.org · www.aasld.org